The use of common heart drugs in conjunction with cancer therapy led to reduced cardiotoxicity in patients with breast and hematological cancers.
Single dose radiotherapy may be as effective as 5 doses for patients with spinal canal compression from metastatic cancer.
The breast cancer expert spoke about the results presented in the trial, noting the benefit seen with longer follow-up.
The nurse practitioner from UCLA Health spoke about the expanding treatment options in this setting.
The expert explained her research focused on the role of CDK4/6 inhibitors in treating breast cancer.
The FDA granted accelerated approval to trastuzumab deruxtecan for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer.
The breast cancer expert discussed 2 advances in HER2-positive breast cancer treatment that healthcare providers should look for.
Seattle Genetics announced the development after data was presented at the 2019 San Antonio Breast Cancer Symposium.
The cancer risk and prevention expert discussed germline testing and the benefits it lends to patients with breast cancer.
The assistant professor from the University of Michigan talked about personalizing radiation treatment in patients with breast cancer and how genomic signatures can be used to identify the radiation needs of patients.